These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Optimization of a Pretargeted Strategy for the PET Imaging of Colorectal Carcinoma via the Modulation of Radioligand Pharmacokinetics. Zeglis BM; Brand C; Abdel-Atti D; Carnazza KE; Cook BE; Carlin S; Reiner T; Lewis JS Mol Pharm; 2015 Oct; 12(10):3575-87. PubMed ID: 26287993 [TBL] [Abstract][Full Text] [Related]
6. A pretargeted PET imaging strategy based on bioorthogonal Diels-Alder click chemistry. Zeglis BM; Sevak KK; Reiner T; Mohindra P; Carlin SD; Zanzonico P; Weissleder R; Lewis JS J Nucl Med; 2013 Aug; 54(8):1389-96. PubMed ID: 23708196 [TBL] [Abstract][Full Text] [Related]
7. Targeting Infiltrating Myeloid Cells in Gastric Cancer Using a Pretargeted Imaging Strategy Based on Bio-Orthogonal Diels-Alder Click Chemistry and Comparison with Zhang Y; Lin Q; Wang T; Shi D; Fu Z; Si Z; Xu Z; Cheng Y; Shi H; Cheng D Mol Pharm; 2022 Jan; 19(1):246-257. PubMed ID: 34816721 [TBL] [Abstract][Full Text] [Related]
9. Radioimmunoimaging of liver metastases with PET using a 64Cu-labeled CEA antibody in transgenic mice. Nittka S; Krueger MA; Shively JE; Boll H; Brockmann MA; Doyon F; Pichler BJ; Neumaier M PLoS One; 2014; 9(9):e106921. PubMed ID: 25226518 [TBL] [Abstract][Full Text] [Related]
10. What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between Bailly C; Gouard S; Guérard F; Chalopin B; Carlier T; Faivre-Chauvet A; Remaud-Le Saëc P; Bourgeois M; Chouin N; Rbah-Vidal L; Tripier R; Haddad F; Kraeber-Bodéré F; Bodet-Milin C; Chérel M Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31137758 [TBL] [Abstract][Full Text] [Related]
11. In vivo evaluation of pretargeted 64Cu for tumor imaging and therapy. Lewis MR; Wang M; Axworthy DB; Theodore LJ; Mallet RW; Fritzberg AR; Welch MJ; Anderson CJ J Nucl Med; 2003 Aug; 44(8):1284-92. PubMed ID: 12902420 [TBL] [Abstract][Full Text] [Related]
15. Harnessing the bioorthogonal inverse electron demand Diels-Alder cycloaddition for pretargeted PET imaging. Reiner T; Lewis JS; Zeglis BM J Vis Exp; 2015 Feb; (96):e52335. PubMed ID: 25742199 [TBL] [Abstract][Full Text] [Related]
16. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer. Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162 [TBL] [Abstract][Full Text] [Related]
17. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [ Lumen D; Vugts D; Chomet M; Imlimthan S; Sarparanta M; Vos R; Schreurs M; Verlaan M; Lang PA; Hippeläinen E; Beaino W; Windhorst AD; Airaksinen AJ Bioconjug Chem; 2022 May; 33(5):956-968. PubMed ID: 35442642 [TBL] [Abstract][Full Text] [Related]
18. Diels-Alder reaction for tumor pretargeting: in vivo chemistry can boost tumor radiation dose compared with directly labeled antibody. Rossin R; Läppchen T; van den Bosch SM; Laforest R; Robillard MS J Nucl Med; 2013 Nov; 54(11):1989-95. PubMed ID: 24092936 [TBL] [Abstract][Full Text] [Related]
19. Site-Specific Photoaffinity Bioconjugation for the Creation of Delaney S; Nagy Á; Karlström AE; Zeglis BM Mol Imaging Biol; 2023 Dec; 25(6):1104-1114. PubMed ID: 37052759 [TBL] [Abstract][Full Text] [Related]
20. Harnessing Keinänen O; Fung K; Brennan JM; Zia N; Harris M; van Dam E; Biggin C; Hedt A; Stoner J; Donnelly PS; Lewis JS; Zeglis BM Proc Natl Acad Sci U S A; 2020 Nov; 117(45):28316-28327. PubMed ID: 33106429 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]